Perturbation study of dissolution apparatus variables—A design of experiment approach

Dissolution Technologies

Volumn 14, Issue 1, 2007, Pages 20-26

  Eaton, Joseph ^a   Deng, Gang ^a   Hauck, Walter W ^a   Brown, William ^a   Manning, Ronald G ^a   Wahab, Samir ^a  

^a UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOLUTION; HEIGHT; REPRODUCIBILITY; ROTATION;

EID: 84962124777     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT140107P20     Document Type: Article

References (16)

1. Montgomery, D. C. Design and Analysis of Experiments, 5th ed.; John Wiley & Sons, Inc.: New York, 2001.
2. Dissolution <711>. In United States Pharmacopeia and National Formulary USP 29-NF 24; The United States Pharmacopeial Convention,Inc.: Rockville, MD, 2006; pp 2675-2682.
3. Nithyananandan, P.; Deng, G.; Brown, W.; Manning, R.; Wahab, S. Evaluation of the Sensitivity of USP Prednisone Tablets to Dissolved Gas in the Dissolution Medium Using USP Apparatus 2. Dissolution Technol. 2006,13 (3),15-18.
4. The USP Council of Experts Biopharmaceutics Expert Committee,Dissolution Advisory Panel,and USP Staff. The USP Performance Verification Test,Part I:Proficiency Testing and the USP Dissolution Procedure. Submitted for publication,2006.
5. Glasgow, M.; Dressman, S.; Brown, W.; Foster, T.; Schuber, S.; Manning, R.; Williams, R. L.; Hauck, W.W. The USP Performance Verification Test,Part II:Collaborative Study of USP’s Lot P Prednisone Tablets. J.Pharm.Sci., in press.
6. Deng, G.; Ashley, A. J.; Brown, W. E.; Eaton, J.W.; Hauck, W. W.; Kikwai-Mutua, L. C.; Liddell, M. R.; Manning, R. G.; Munoz, J. M.; Nithyanandan, P.; Glasgow, M. J.; Stippler, E.; Wahab, S. Z.; Williams, R. L. The USP Performance Verification Test,Part III:USP Lot P Prednisone Tablets—Quality Attributes and Experimental Variables Contributing to Dissolution Variance. Submitted for publication,2006.
7. PhRMA Subcommittee on Dissolution Calibration. Dissolution Calibration:Recommendations for Reduced Chemical Testing and Enhanced Mechanical Calibration. Pharm.Forum 2000,26 (4),1149-1166.
8. Qureshi, S. A.; McGilveray, I. J. Typical Variability in Drug Dissolution Testing:Study with USP and FDA Calibrator Tablets and a Marketed Drug (Glibenclamide) Product. Eur. J. Pharm.Sci. 1999,7,249-258.
9. Mirza, T.; Joshi, Y.; Liu, Q.; Vivilecchia, R. Evaluation of Dissolution Hydrodynamics in the USP,Peak,and Flat-Bottom Vessels Using Different Solubility Drugs. Dissolution Technol. 2005,12 (1),11-16.
10. Crist, B.; Spisak, D. Evaluation of Induced Variance of Physical Parameters on the Calibrated USP Dissolution Apparatus 1 and 2. Dissolution Technol. 2005,12 (1),28-31.
11. Tanaka, M.; Fujiwara, H.; Fujiwara, M. Effect of Irregular Inner Shape of a Glass Vessel on Prednisone Dissolution Results. Dissolution Technol. 2005,12 (4),15-19.
12. Gao, Z.; Moore, T.W.; Doub, W. H.; Westenberger, B. J.; Buhse, L. F. Effects of Deaeration Methods on Dissolution Testing in Aqueous Media:A Study Using a Total Dissolved Gas Pressure Meter. J.Pharm.Sci. 2006,95 (7),1606-1613.
13. ASTM WK9936. New Standard Practice for Qualification of Basket and Paddle Dissolution Apparatus. ASTM International: West Conshohocken,PA.
14. United States Pharmacopeia. USP Prednisone Tablets RS Lot P0E203,Disintegrating Tablets for Dissolution Performance Verification Test; Specification Sheet; United States Pharmacopeial Convention,Inc.:Rockville,MD.
15. Scott, P. Geometric Irregularities Common to the Dissolution Vessel. Dissolution Technol. 2005,12 (1),18-21.
16. Liddell, M.; Deng, G.; Hauck, W.W.; Brown, W. E.; Wahab, S. Z.; Manning, R. G. Evaluation of Glass Dissolution Vessel Dimensions and Irregularities. Dissolution Technol. 2007,14 (1),28-33.